최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기藥劑學會誌 = Journal of Korean pharmaceutical sciences, v.36 no.4, 2006년, pp.263 - 269
Deficiencies in the early ADMET(absorption, distribution, metabolism, elimination and toxicity) information on drug candidate extract a significant economic penalty on pharmaceutical firms. Microscale cell culture analogue-microscale gastrointestinal(
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
L.M. Sweeny, M.L. Shuler, J.G. Babish and A. Ghanem, A cell culture analogue of rodent physiology: application to naphthalene toxicology, Toxicol in Vitro., 59, 307-316 (1995)
K. Viravaidya and M.L. Shuler, Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analogue device for toxicity studies, Biotechnol. Prog., 20, 590-597 (2004)
D.G. Davidson and W.N. Eastham, Acute liver necrosis following overdose of paracetamol, Br. Med. J., 5512, 497-499 (1966)
J.R. Mitchell, Acetaminophen toxicity, N. Engl. J. Med., 31, 1601-1602 (1988)
T. Ishida, M. Abe, K. Oguri and H. Yamada, Enhancement of acetaminophen cytotoxicity in selenium-binding protein-overexpressed COS-1 Cells, Drug Metab. Pharmacokin, 19, 290-296 (2004)
J.D Gibson, N.R. Pumford, V.M. Samokyszyn and J.A. Hinson, Mechanism of acetaminophen-induced hepatotoxi-city: covalent binding versus oxidative stress, Chem. Res. Toxicol., 9, 580-585 (1996)
J.A. Brent and B.H. Rumack, Role of free radicals in toxic hepatic injury. II Are free radicals the cause of toxin-induced liver injury.? J. Toxicol. Clin. Toxicol., 31, 173-196 (1993)
J. Liu, Y. Liu, D. Hartley, C.D. Klaassen, S.E. Shehin-Johnson, A. Lucas and S.D. Cohen, Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity, J. Pharmacol. Exp. Ther., 289, 580-586 (1999)
S.H. Choi, M. Nishikawa, A. Sakoda and Y. Sakai, Feasibility of a simple double-layered coculture system incorporating metabolic processes of the intestine and liver tissue: application to the analysis of benzo[a]pyrene toxicity, Toxicol. in Vitro., 18, 393-402 (2004)
B. Davies and T. Morris, Physiological parameters in laboratory animals and humans, Pharm. Res., 7, 1093-1095 (1993)
R.D. Kanter, M. Monshouwer, A.L. Draaisa, M.H. De Jager, I.A.M. De Graaf, J.H. Proost, D.K.F. Meijer and G.M.M. Groothuis, Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon, Xenobio., 24, 229-241 (2004)
A. Sin, K.C. Chin, M.F. Jamil, Y. Kostov, G. Rao and M.L. Shuler, The design and fabrication of three chamber microscale cell culture analogue devices with integrated dissolved oxygen sensors, Biotechnol. Prog., 20, 338-345 (2004)
P.T. Manyike, E.D. Kharasch, T.F. Kalhorn and J.T. Salttery, Contribution of CYP 2E1 and CYP 3A to acetaminophen reactive metabolite formation, Clin. Pharm & Therapeu., 67, 275-282 (2000)
S.D. Nelson, Mechanism of the formation and disposition of reactive metabolites that can cause acute liver injury, Drug Met. Res., 27, 147-177 (1995)
V. Carriere, J. Chambaz and M. Rousset, Intestinal response to xenobiotics, Toxicol. in Vitro., 15, 373-378 (2001)
D.W. Rosenberg and T. Leff, Regulation of cytochrome P450 in cultured human colonic cells, Arch. Biochem. Biophy., 300, 186-192 (1993)
J.M. Gearhart, G.W. Jepson, H.J. Clewell, M.E. Anderson and R.B. Conolly, Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetyl-cholinesterase by disodiumpropylfluorophosphate, Toxicol. Applied Pharm., 106, 295-310 (1990)
S. Rendic and F.J. Dicarlo, Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors, Drug Metab. Rev., 29, 413-80 (1997)
T. Prueksaritanout, L.M. Gorham, J.H. Hochman, L.O. Tran and K.P. Vyas, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines and in Caco-2 cells, Drug Metab. Dispos., 24, 634-642 (1996)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.